上海百心安生物技术股份有限公司（股票代码：02185）于2026年6月4日发布2026年5月股份变动月报表，报告期截至2026年5月31日。
根据公告，百心安-B本月内普通股包括于香港联交所上市的H股（股票代码02185）和非上市外资股，合计法定注册股本243,417,100元人民币。本月末，H股股本为235,703,422股，非上市外资股为7,713,678股，较上月均无增减变化，公司已发行股份及库存股总数维持不变，未发生新的发行、购回、注销或库藏股活动。本月公司无股份期权、权证及可换股票据的新增或变动。
公司确认已持续符合香港联交所证券上市规则相关规定。本次公告由执行董事兼联席公司秘书王云磬签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.